Search - tctmd.com

Displaying 41 - 60 of 61

Sort: Relevancy | Date

Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients

News Conference News ACC 2020

Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients

April 01, 2020

Future Pulmonary Embolism Interventions: Wild West or Working Together?

News Conference News VIVA 2019

Future Pulmonary Embolism Interventions: Wild West or Working Together?

November 14, 2019

Interventional Options and Future Directions for Acute PE: New AHA Statement

News Daily News

Interventional Options and Future Directions for Acute PE: New AHA Statement

October 07, 2019

ESC Updates Guidance on Management of Acute Pulmonary Embolism

News Conference News ESC 2019

ESC Updates Guidance on Management of Acute Pulmonary Embolism

September 06, 2019

Off Script: Through ‘Paclitaxelgate,’ Some Upsides to Uncertainty

News Opinion Off Script

Off Script: Through ‘Paclitaxelgate,’ Some Upsides to Uncertainty

Sahil Parikh, MD

July 29, 2019

Vici Venous Stent Shows Good Primary Patency, Few MAE by 12 Months: VIRTUS

News Conference News ISET 2019

Vici Venous Stent Shows Good Primary Patency, Few MAE by 12 Months: VIRTUS

February 08, 2019

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

News Daily News

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

January 10, 2019

Top News in Endovascular Therapy: 2018

News Features

Top News in Endovascular Therapy: 2018

December 28, 2018

NOACs Significantly Curb Risk of VTE in Cancer Patients

News Daily News

NOACs Significantly Curb Risk of VTE in Cancer Patients

December 06, 2018

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

News Daily News

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

November 02, 2018

TCTMD’s Top 10 Most Popular Stories for August 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2018

September 04, 2018

MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis

News Conference News ESC 2018

MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis

August 26, 2018

No Benefits, Higher Costs With IVC Filters in Catheter-Directed Thrombolysis for DVT

News Daily News

No Benefits, Higher Costs With IVC Filters in Catheter-Directed Thrombolysis for DVT

Michael O'Riordan

July 23, 2018

News Features

Coalition of the Willing: PERTs Aim to Disentangle ‘Gordian Knot’ of Acute Pulmonary Embolism

January 02, 2017

News Daily News

Questions Over Risk-Benefit Balance for IVC Filters Still Vex Clinicians

November 17, 2016

News Daily News

Catheter-Directed Thrombolysis for DVT Increases Bleeding Compared With Standard Anticoagulation

July 24, 2014

News Daily News

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Yael L. Maxwell

January 01, 2014

News Daily News

Endovascular Therapy for DVT Appears Safe, Effective in Registries

January 22, 2013

Late Breaking Clinical Trials: Venous Thromboembolic Disease EINSTEIN-PE (Rivaroxaban)

Presentation TCT 2012

Late Breaking Clinical Trials: Venous Thromboembolic Disease EINSTEIN-PE (Rivaroxaban)

Presenter: Jeffrey Kuvin

October 23, 2012

News Daily News

Single-Center Studies Build Case for Venous Angioplasty in Multiple Sclerosis

April 05, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.